Regencell Bioscience Holdings Stock Price Prediction
| RGC Stock | USD 13.97 0.79 5.99% |
Momentum 46
Impartial
Oversold | Overbought |
Using Regencell Bioscience hype-based prediction, you can estimate the value of Regencell Bioscience Holdings from the perspective of Regencell Bioscience response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Regencell Bioscience using Regencell Bioscience's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Regencell using crowd psychology based on the activity and movement of Regencell Bioscience's stock price.
Regencell Bioscience Short Interest
A significant increase or decrease in Regencell Bioscience's short interest from the previous month could be a good indicator of investor sentiment towards Regencell. Short interest can provide insight into the potential direction of Regencell Bioscience stock and how bullish or bearish investors feel about the market overall.
200 Day MA 5.9119 | Short Percent 0.0197 | Short Ratio 0.64 | Shares Short Prior Month 1.2 M | 50 Day MA 19.7673 |
Regencell Bioscience Hype to Price Pattern
Investor biases related to Regencell Bioscience's public news can be used to forecast risks associated with an investment in Regencell. The trend in average sentiment can be used to explain how an investor holding Regencell can time the market purely based on public headlines and social activities around Regencell Bioscience Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Regencell Bioscience's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Regencell Bioscience.
Regencell Bioscience Implied Volatility | 2.37 |
Regencell Bioscience's implied volatility exposes the market's sentiment of Regencell Bioscience Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regencell Bioscience's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regencell Bioscience stock will not fluctuate a lot when Regencell Bioscience's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Regencell Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Regencell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regencell Bioscience after-hype prediction price | USD 18.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Regencell contract
Based on the Rule 16, the options market is currently suggesting that Regencell Bioscience Holdings will have an average daily up or down price movement of about 0.15% per day over the life of the 2025-09-19 option contract. With Regencell Bioscience trading at USD 13.97, that is roughly USD 0.0207 . If you think that the market is fully incorporating Regencell Bioscience's daily price movement you should consider acquiring Regencell Bioscience Holdings options at the current volatility level of 2.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Regencell | Build AI portfolio with Regencell Stock |
Regencell Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Regencell Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regencell Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regencell Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regencell Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Regencell Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regencell Bioscience's historical news coverage. Regencell Bioscience's after-hype downside and upside margins for the prediction period are 0.93 and 60.43, respectively. We have considered Regencell Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regencell Bioscience is dangerous at this time. Analysis and calculation of next after-hype price of Regencell Bioscience is based on 3 months time horizon.
Regencell Bioscience Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Regencell Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regencell Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regencell Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.42 | 41.86 | 4.60 | 0.72 | 11 Events / Month | 5 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.97 | 18.57 | 32.93 |
|
Regencell Bioscience Hype Timeline
On the 9th of August Regencell Bioscience is traded for 13.97. The entity has historical hype elasticity of 4.6, and average elasticity to hype of competition of -0.72. Regencell is forecasted to increase in value after the next headline, with the price projected to jump to 18.57 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 32.93%, whereas the daily expected return is at this time at 4.42%. The volatility of related hype on Regencell Bioscience is about 25628.57%, with the expected price after the next announcement by competition of 13.25. Regencell Bioscience Holdings has 85.74 K in debt with debt to equity (D/E) ratio of 0.07, which may show that the company is not taking advantage of profits from borrowing. Regencell Bioscience has a current ratio of 13.66, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Regencell to invest in growth at high rates of return. Considering the 90-day investment horizon the next forecasted press release will be in about 11 days. Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections.Regencell Bioscience Related Hype Analysis
Having access to credible news sources related to Regencell Bioscience's direct competition is more important than ever and may enhance your ability to predict Regencell Bioscience's future price movements. Getting to know how Regencell Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regencell Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LIEN | Chicago Atlantic BDC, | (0.75) | 17 per month | 1.83 | (0.03) | 2.94 | (2.95) | 12.77 | |
| SHPHF | Sihuan Pharmaceutical Holdings | 0.00 | 0 per month | 0.00 | (0.18) | 0.00 | 0.00 | 16.67 | |
| PAHC | Phibro Animal Health | (0.17) | 9 per month | 1.56 | 0.17 | 5.23 | (3.15) | 19.86 | |
| EGRX | Eagle Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CNK | Cinemark Holdings | (0.28) | 9 per month | 0.00 | (0.19) | 2.61 | (2.92) | 9.80 | |
| VRPX | Virpax Pharmaceuticals | 0.11 | 26 per month | 0.00 | (0.39) | 7.91 | (17.20) | 78.40 | |
| RNXT | RenovoRx | 0.11 | 8 per month | 2.48 | 0.03 | 5.08 | (4.41) | 14.24 | |
| NCMI | National CineMedia | (0.1) | 9 per month | 0.00 | (0.15) | 3.30 | (4.62) | 18.36 | |
| RGS | Regis Common | (0.39) | 9 per month | 2.45 | (0) | 4.43 | (3.76) | 16.45 |
Regencell Bioscience Additional Predictive Modules
Most predictive techniques to examine Regencell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regencell using various technical indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regencell Bioscience Predictive Indicators
The successful prediction of Regencell Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regencell Bioscience Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience based on analysis of Regencell Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regencell Bioscience's related companies.
Story Coverage note for Regencell Bioscience
The number of cover stories for Regencell Bioscience depends on current market conditions and Regencell Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regencell Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regencell Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regencell Bioscience Short Properties
Regencell Bioscience's future price predictability will typically decrease when Regencell Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regencell Bioscience Holdings often depends not only on the future outlook of the potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 494.5 M | |
| Cash And Short Term Investments | 8 M |
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |